Estrogen Receptor Agonism is the pharmacological or physiological event where a molecule binds to an estrogen receptor (ER) and activates it, initiating a downstream transcriptional response similar to that of endogenous estradiol. This action stimulates estrogen-dependent cellular activities, which can be beneficial or detrimental depending on the tissue context and the specific receptor subtype involved. Clinical management often hinges on understanding the selectivity of the agonist.
Origin
This terminology is derived from pharmacology, combining the specificity of ‘estrogen receptor’ with the concept of ‘agonism,’ meaning an activator or mimic of a natural substance’s effect. It describes a molecular interaction that successfully switches on the estrogen signaling pathway.
Mechanism
The agonist molecule enters the cell, binds to the ligand-binding domain of the ER, inducing a conformational change that allows the receptor to dimerize and translocate to the nucleus. There, the activated complex binds to estrogen response elements on the DNA, recruiting co-activator proteins to initiate target gene transcription relevant to proliferation or differentiation.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.